Polygiene launches ViralOff, a Polygiene technology

The application for the ViralOff® antiviral technology will range from medical equipment and wear, like scrubs and uniforms to consumer products where antiviral properties make sense, like face masks, gloves and other crucial products. The new product will be available immediately in most markets.*

The application for the ViralOff® antiviral technology will range from medical equipment and wear, like scrubs and uniforms to consumer products where antiviral properties make sense, like face masks, gloves and other crucial products. The new product will be available immediately in most markets.*

Back in 2004, the SARS epidemic was raging. Demand for antiviral and antibacterial treatments was soaring. As smart scientists and technicians at the Swedish chemical company Perstorp came up with new solutions, a new company was spun off – Polygiene. But the memory of SARS waned, and we focused instead on consumer products and the environmental benefit of washing less and making garments more sustainable. Now Corona has changed the world. So, we have rapidly gone back to our roots in the healthcare sector and our know-how and learnings on combating viruses, and today we announce the launch of a new product – ViralOff®, a Polygiene technology.

On a garment treated with ViralOff, over 99% of viruses will be killed in 2 hours as per a ISO18184:2019 test. All viruses so far tested, from Influenza A, BirdFlu, Norovirus and to Corona (SARS) viruses are reduced in the 99% range. As this testing procedure is central, the ViralOff brand will serve as a stamp of assurance that the product lives up to a standard.

“Think of it as a sanitizer for garments.”, says Ulrika Björk, CEO Polygiene. “There is an enormous demand for things that help combat viruses now. With the ViralOff treatment, we can help set a standard for performance and help everyone get through these difficult times, from the heroes working in the medical services to the average person who would just like to get a pair of gloves or a facemask with tested antiviral capability.”

We also anticipate and welcome other novel product ideas from scientists and inventors that use this functionality.

*the product is not yet approved for use by the US FDA and US EPA.